NewAmsterdam Pharma NAMS
NASDAQ NAMS
$19.18 +0.18 (+0.95%)
At close: Nov 10, 2026 · 4:00 PM EST

NewAmsterdam Pharma (NAMS) Total Non-Current Liabilities (2021 - 2024)

Updated

NewAmsterdam Pharma (NAMS) recorded Total Non-Current Liabilities of $41.52 million in Q3 2024, down 9.5% from the prior quarter.

Analysis

NewAmsterdam Pharma (NAMS) Total Non-Current Liabilities (2021 - 2024) Analysis & Trends

At the end of FY2023, NewAmsterdam Pharma reported Total Non-Current Liabilities of $50.92 million, up 311.7% from FY2022.

  • Across earlier years, Total Non-Current Liabilities came in at $12.37 million in FY2022 and $125,708 in FY2021.
  • The Q3 2024 figure is the lowest quarterly Total Non-Current Liabilities since Q2 2023.
  • Per Business Quant, the preceding three quarters came in at $45.86 million (Q2 2024), $60.17 million (Q1 2024) and $50.92 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 102.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 117.60 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 33.91 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 96.04 Bn
10 NewAmsterdam Pharma 2.43 Bn -108.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 41.52 Mn
Jun 30, 2024 45.86 Mn
Mar 31, 2024 60.17 Mn
Dec 31, 2023 50.92 Mn
Jun 30, 2023 11.41 Mn
Dec 31, 2022 12.37 Mn
Dec 31, 2021 125,707.81
API Access

NewAmsterdam Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NAMS&period=max&api_key=YOUR_API_KEY